Search - tctmd.com

Displaying 101 - 120 of 630

Sort: Relevancy | Date

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

Presenter: Steven Yakubov

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

Presenter: Atsushi Okada

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

Caitlin E. Cox

October 16, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Daily News

Cardiology Society Leaders Expand on Vision for New Medical Board

Todd Neale

October 05, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

Todd Neale

August 01, 2023

News Daily News

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

Caitlin E. Cox

July 21, 2023

News Daily News

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Caitlin E. Cox

July 13, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

Presentation TVT 2023

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Presenter: Wah Wah Htun

June 09, 2023

News Conference News TVT 2023

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Presenter: Amit Vora

June 08, 2023

Presentation TVT 2023

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Presenter: Amit Vora

June 07, 2023

Advertisement

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 383: Feasibility of TAV-in-TAV in Evolut valves using in-vivo CT sizing and its impact on coronary obstruction and patient prosthesis mismatch

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

What’s Going to Be Hot at TCT 2023

US Cardiologists’ Pay, Productivity Held Steady in 2022: MedAxiom Survey

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Cardiology Society Leaders Expand on Vision for New Medical Board

October 2023 News Roundup

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices

For Moderate AS Patients, Baseline Factors Can Help ID Who’s Most at Risk

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Real-World Early Outcomes of Evolut FX Versus PRO+ Transcatheter Aortic Valve Replacement

Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content